Factor V Leiden and Morbid Obesity in Fatal Postoperative Pulmonary Embolism
Open Access
- 1 December 2000
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Surgery
- Vol. 135 (12) , 1410-1413
- https://doi.org/10.1001/archsurg.135.12.1410
Abstract
VENOUS thromboembolism is associated with more than 300 000 hospitalizations annually in the United States,1 and acute pulmonary embolism (APE) is directly responsible for 50 000 to 100 000 deaths each year.1-3 Because venous thromboembolism is rare in the general population, identification of individuals at risk and provision of attendant prophylaxis may offer a potential public health benefit. Many risk factors for APE have been convincingly demonstrated, including prior thromboembolism, major surgery, malignancy, multiple trauma and fractures, varicose veins, pregnancy and puerperium, cardiac and neurologic disease, advanced age, and estrogen therapy, with prolonged immobilization probably representing the predominant common denominator.2,4Keywords
This publication has 13 references indexed in Scilit:
- The Disease Burden Associated With Overweight and ObesityJAMA, 1999
- Annual Deaths Attributable to Obesity in the United StatesJAMA, 1999
- Death from pulmonary thromboembolism in severe obesity: lack of association with established genetic and clinical risk factors.Virchows Archiv, 1999
- Activated Protein C Resistance and Factor V Leiden Mutation Are Independent Risk Factors for Venous ThromboembolismAnnals of Internal Medicine, 1999
- Venous thrombosis: a multicausal diseaseThe Lancet, 1999
- Epidemiology of Factor V Leiden: Clinical ImplicationsSeminars in Thrombosis and Hemostasis, 1998
- Factor V Leiden Mutation and the Risks for Thromboembolic Disease: A Clinical PerspectiveAnnals of Internal Medicine, 1997
- Social and economic effects of body weight in the United StatesThe American Journal of Clinical Nutrition, 1996
- Preparation of Nucleic Acids for Archival MaterialPublished by Springer Nature ,1994
- Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.Proceedings of the National Academy of Sciences, 1993